ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

LIFE aTyr Pharma Inc

1,59
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:00:01
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
aTyr Pharma Inc LIFE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 1,59 10:00:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,59
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.4.202414:00GLOBEaTyr Pharma to Participate in April Investor Conferences
14.3.202421:00GLOBEaTyr Pharma Announces Fourth Quarter and Full Year 2023..
28.2.202414:00GLOBEaTyr Pharma to Webcast Conference Call Reporting Fourth..
21.2.202414:00GLOBEaTyr Pharma Announces Expanded Access Program (EAP) for..
07.2.202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.1.202414:00GLOBEaTyr Pharma to Present Posters Highlighting Importance of..
18.1.202414:00GLOBEaTyr Pharma Announces Howard University President Emeritus..
10.1.202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202418:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13.12.202300:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13.11.202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202314:00GLOBEaTyr Pharma Presents Poster Demonstrating Preclinical..
09.11.202323:01EDGAR2Form S-3 - Registration statement under Securities Act of..
09.11.202322:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09.11.202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:06EDGAR2Form 8-K - Current report
09.11.202322:00GLOBEaTyr Pharma Announces Third Quarter 2023 Results and..
01.11.202313:00GLOBEaTyr Pharma to Present at November Investor Conferences
31.10.202313:00GLOBEaTyr Pharma Announces Dosing of First Patient in Phase 2..
26.9.202315:01EDGAR2Form 8-K - Current report
11.9.202314:04EDGAR2Form 8-K - Current report
11.9.202314:00GLOBEaTyr Pharma Presents Efzofitimod Data Demonstrating..
24.8.202314:00GLOBEaTyr Pharma to Present at the H.C. Wainwright 25th Annual..
10.8.202322:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
09.8.202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202322:10EDGAR2Form 8-K - Current report
09.8.202322:00GLOBEaTyr Pharma Announces Second Quarter 2023 Results and..
01.8.202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.6.202314:00GLOBEEuropean Commission Grants Orphan Drug Designation for aTyr..
20.6.202314:00GLOBEaTyr Pharma to Present on Lead Therapeutic Candidate..
09.6.202322:00GLOBEaTyr Pharma Announces Inducement Grants Under Nasdaq Listing..
06.6.202314:00GLOBEaTyr Pharma to Highlight Advancements in tRNA Synthetase..
25.5.202314:00GLOBEaTyr Pharma to Present at the 2023 Jefferies Healthcare..
22.5.202314:00GLOBEaTyr Pharma Presents New Data on Efzofitimod Mechanism of..
11.5.202322:00GLOBEaTyr Pharma to Present at the 2023 RBC Capital Markets..
09.5.202322:00GLOBEaTyr Pharma Announces First Quarter 2023 Results and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock